03 May 2023 P95 BV and Ampersand Capital Partners join forces to establish first in class vaccine CRO Member news
26 Apr 2023 VIB and Ghent University develop new mRNA vaccines against bacterial infections Member news
25 Apr 2023 Flanders export figures 2022: goods exports up 26%, but growth has slowed since Q4 Member news
27 Mar 2023 HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platform Member news
27 Mar 2023 ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI Member news
02 Mar 2023 VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology Member news
02 Mar 2023 Oxurion announces subscription agreement with Atlas providing the company with up to €20 million in funding Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
